Paul Richins compensation by year
UTAH MEDICAL PRODUCTS Summary Compensation Table · all 3 fiscal years held| Component | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Salary | $116,678 | $118,507 | $39,827 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $0 | $0 | $0 |
| Non-equity incentive | $20,293 | $24,292 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $3,876 | $3,931 | $1,702 |
| Total | $140,847 | $146,730 | $41,529 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: UTAH MEDICAL PRODUCTS INC DEF 14A filed April 12, 2021, accession 0001096906-21-000735, and prior-year filings. Open the filing on EDGAR.
How this page was built: the UTAH MEDICAL PRODUCTS INC filed document, accession 0001096906-21-000735. Every figure is read from that document and cited to the page and table it appears in. Filed April 12, 2021.
Insider transactions since the last proxy
3 Form 4 lines since the FY2018 proxy (filed April 12, 2021)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-06-29 | Gift | — | 150 | $73.07 | 20,765 |
| 2025-08-25 | Gift | — | 100 | $60.34 | 21,136 |
| 2024-05-17 | Gift | — | 225 | $69.72 | 21,236 |
The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
UTAH MEDICAL PRODUCTS’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Kevin Cornwell | Chairman & CEO | $501,300 |
| Brian Koopman | Principal Financial Officer | $120,343 |
| Paul Richins · this page | VP & Principal Financial Officer | $41,529 |
Board service
UTAH MEDICAL PRODUCTS board · FY2021–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $30,600 | $0 | $0 | $0 | $30,600 |
| FY2024 | $29,400 | $0 | $0 | $0 | $29,400 |
| FY2023 | $29,400 | $0 | $0 | $0 | $29,400 |
| FY2022 | $28,000 | $0 | $0 | — | $28,000 |
| FY2021 | $28,000 | $0 | $0 | $0 | $28,000 |
Each year as the company reported it in UTAH MEDICAL PRODUCTS's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: UTAH MEDICAL PRODUCTS pays directors a $30,600 cash retainer. As stated in UTAH MEDICAL PRODUCTS's FY2025 proxy.
Committees
Audit · Nominating/Governance
The full UTAH MEDICAL PRODUCTS compensation record
free company briefThis page is one person within UTAH MEDICAL PRODUCTS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are UTAH MEDICAL PRODUCTS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.